Where Phosphorylated Tau (p-tau181) is reported
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Alzheimer's Disease and Other Dementias | ↑ elevated | AD vs healthy/non-AD (core CSF/plasma biomarker) | — | Abukuri et al. 2024 |
Frequently asked questions
In which conditions is Phosphorylated Tau (p-tau181) altered?
In the OSMF atlas Phosphorylated Tau (p-tau181) is reported in Alzheimer's Disease and Other Dementias. It is elevated in 1 across 1 entries.
Is there a standard clinical test for Phosphorylated Tau (p-tau181)?
The atlas entries for Phosphorylated Tau (p-tau181) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal Phosphorylated Tau (p-tau181) result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-07-03 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.